RapidClaims
PrivateLast Round
Series A
Apr 2, 2025
Total Funding Raised
$11.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
RapidClaims operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in April 2025.
RapidClaims is a healthcare technology company that provides an AI-powered revenue cycle management platform to help healthcare providers automate medical coding, reduce claim denials, and improve billing efficiency.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Medical AI, Healthcare Analytics, Workflow Automation
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RapidClaims Comparables
Compare RapidClaims with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arintra | 93% | |
| XpertDox | 88% | |
| Nym | 85% |
For institutional investors. Book with your work email.
RapidClaims Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 2, 2025 | ||||
| Seed | Feb 15, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RapidClaims Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DeVC | Seed |
| Better Capital | Seed |
| Neon Fund | Seed |
| peercheque | Seed |
| Better Capital | Seed |
| Together Fund | Series A, Seed |
| Accel | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2026
Grew 27% QoQ, from 86 to 109 employees.
- Sep 1, 2026
Grew 23% QoQ, from 83 to 102 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingNov 5, 2026
Reports state that RapidClaims is in talks to raise $30M in a Series B financing led by WestBridge Capital, with existing investors Accel and Together Fund likely to participate, but its founder denies the talks in Nov '26.
- attends_eventSep 15, 2026
At HIMSS 2026, RapidClaims showcases revenue cycle management software as health systems prioritize AI-driven billing.
For institutional investors. Book with your work email.
RapidClaims Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RapidClaims's valuation, stock price, and market status.
Is RapidClaims a public or private company?
RapidClaims is a private company.
What is the current stock price of RapidClaims?
RapidClaims is a private company, so its shares have no public market price. Caplight tracks RapidClaims's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RapidClaims worth (valuation)?
Valuation information for RapidClaims is not publicly available.
Can I buy RapidClaims stock?
RapidClaims shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RapidClaims's last funding round?
RapidClaims's most recent funding round was Series A on April 2, 2025.
Who are the main investors in RapidClaims?
Key investors in RapidClaims include Together Fund, Accel.
Will RapidClaims IPO soon?
No public IPO plans have been announced for RapidClaims.
How can I track RapidClaims secondary market activity?
Caplight tracks bids, offers, and trades in RapidClaims's shares on secondary markets.